Clover Health Investments Corp
NASDAQ:CLOV

Watchlist Manager
Clover Health Investments Corp Logo
Clover Health Investments Corp
NASDAQ:CLOV
Watchlist
Price: 1.82 USD -1.62% Market Closed
Market Cap: $954.9m

EV/EBITDA

-9.8
Current
11%
More Expensive
vs 3-y median of -8.8

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
-9.8
=
Enterprise Value
$902.3m
/
EBITDA
$-83.8m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
-9.8
=
Enterprise Value
$902.3m
/
EBITDA
$-83.8m

Valuation Scenarios

Clover Health Investments Corp is trading above its industry average

If EV/EBITDA returns to its Industry Average (12.9), the stock would be worth $-2.38 (231% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-246%
Maximum Upside
No Upside Scenarios
Average Downside
238%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple -9.8 $1.82
0%
Industry Average 12.9 $-2.38
-231%
Country Average 14.4 $-2.66
-246%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
$902.3m
/
Jan 2026
$-83.8m
=
-9.8
Current
$902.3m
/
Dec 2026
$49.3m
=
18.3
Forward
$902.3m
/
Dec 2027
$68.6m
=
13.2
Forward
$902.3m
/
Dec 2028
$110.8m
=
8.1
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
US
Clover Health Investments Corp
NASDAQ:CLOV
944.7m USD -9.8 -11
US
UnitedHealth Group Inc
NYSE:UNH
246.6B USD 0 20.5
US
Anthem Inc
LSE:0HG8
74.2B USD 0 13.1
US
Elevance Health Inc
NYSE:ELV
64.1B USD 0 11.3
US
Humana Inc
NYSE:HUM
20.8B USD 0 17.5
US
Centene Corp
NYSE:CNC
16.2B USD 0 -2.4
US
Molina Healthcare Inc
NYSE:MOH
7.2B USD 3 15.3
US
Healthequity Inc
NASDAQ:HQY
7B USD 15.8 32.4
US
Magellan Health Inc
F:MAH1
2.2B EUR 12.9 8.5
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 11.4 25.2
BR
Odontoprev SA
BOVESPA:ODPV3
7.2B BRL 8.4 12.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Clover Health Investments Corp
NASDAQ:CLOV
Average EV/EBITDA: 10.3
Negative Multiple: -9.8
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
Not Available N/A N/A
US
A
Anthem Inc
LSE:0HG8
Not Available N/A N/A
US
Elevance Health Inc
NYSE:ELV
Not Available N/A N/A
US
Humana Inc
NYSE:HUM
Not Available N/A N/A
US
Centene Corp
NYSE:CNC
Not Available N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
3
10%
0.3
US
Healthequity Inc
NASDAQ:HQY
15.8
N/A N/A
US
M
Magellan Health Inc
F:MAH1
12.9
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
11.4
44%
0.3
BR
Odontoprev SA
BOVESPA:ODPV3
8.4
4%
2.1
P/E Multiple
Earnings Growth PEG
US
Clover Health Investments Corp
NASDAQ:CLOV
Average P/E: 17.4
Negative Multiple: -11
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
20.5
21%
1
US
A
Anthem Inc
LSE:0HG8
13.1
11%
1.2
US
Elevance Health Inc
NYSE:ELV
11.3
11%
1
US
Humana Inc
NYSE:HUM
17.5
37%
0.5
US
Centene Corp
NYSE:CNC
Negative Multiple: -2.4 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
15.3
19%
0.8
US
Healthequity Inc
NASDAQ:HQY
32.4
N/A N/A
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
25.2
32%
0.8
BR
Odontoprev SA
BOVESPA:ODPV3
12.4
4%
3.1

Market Distribution

Lower than 100% of companies in the United States of America
Percentile
0th
Based on 9 875 companies
0th percentile
-9.8
Low
0 — 10
Typical Range
10 — 21.5
High
21.5 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 10
Median 14.4
70th Percentile 21.5
Max 1 767 274.1

Clover Health Investments Corp
Glance View

Market Cap
954.9m USD
Industry
Health Care

Clover Health Investments Corp. embarked on a mission to transform the healthcare landscape with its innovative approach as a next-generation Medicare Advantage insurer. Born out of the need to reduce inefficiencies and enhance care, Clover Health uses its proprietary technology platform, the Clover Assistant, to arm physicians with data-driven insights that facilitate informed decision-making at the point of care. By integrating technology with healthcare delivery, Clover targets not only the evident administrative wastage but also addresses the structural challenges faced by patients and providers alike. This unique integration of digital tools with a traditional insurance model sets Clover apart in an industry ripe for disruption. Revenue for Clover Health primarily comes from Medicare Advantage premiums, where it competes by offering cost-effective plans combined with improved service. The company augments its financial model through government reimbursements tied to patient outcomes and the quality of care. Central to this strategy is the effective use of data analytics to manage patient care, reduce medical costs, and improve customer satisfaction. This alignment of financial incentives—lowering costs while enhancing patient outcomes—fuels Clover’s growth narrative, positioning it as a key player in reshaping how Medicare Advantage operates at the intersection of technology and healthcare delivery.

CLOV Intrinsic Value
2.64 USD
Undervaluation 31%
Intrinsic Value
Price
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett